{"id":"W2980707925","doi":"10.1177/2055217319879952","title":"Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Chugai Pharmaceutical; Multiple Sclerosis Society of Canada; Acorda Therapeutics; EMD Serono; Vancouver Coastal Health Research Institute; Michael Smith Health Research BC; Vertex Pharmaceuticals; Multiple Sclerosis Society; Sanofi Genzyme; F. Hoffmann-La Roche; Teva Pharmaceutical Industries; Biogen; Celgene; Sanofi","keywords":"Ocrelizumab; Gliosis; Medicine; Interferon beta; Magnetic resonance imaging; Multiple sclerosis; Internal medicine; Oncology; Nuclear magnetic resonance; Immunology; Pathology; Radiology; Physics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006799491,0.0003443261,0.0007364871,0.000186017,0.0002337372,0.00009692538,0.0001770954,0.0001581435,0.0002910548],"category_scores_gemma":[0.0004052633,0.0002633434,0.0003020909,0.0002476682,0.0003021246,0.0003979247,0.00005848425,0.0006227559,0.00001956979],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001891016,"about_ca_system_score_gemma":0.000113256,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005512037,"about_ca_topic_score_gemma":0.00008034052,"domain_scores_codex":[0.996677,0.0001961735,0.001124372,0.000663417,0.0007913194,0.0005477564],"domain_scores_gemma":[0.9966016,0.002379867,0.0001970337,0.0002150815,0.0002528906,0.0003534677],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04931908,0.001190379,0.9255981,0.00004083923,0.0001357847,0.000005456227,0.0003458619,0.00001402387,0.01383463,0.00001490312,0.00008896074,0.009411952],"study_design_scores_gemma":[0.04139028,0.01440521,0.9336239,0.00158039,0.00007913717,0.000009659603,0.0003134604,0.002525766,0.005511502,0.000008940849,0.0002635375,0.0002882268],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915432,0.00572459,0.00008454716,0.0008715726,0.0002602577,0.001304099,0.0000433739,0.00002682362,0.0001415739],"genre_scores_gemma":[0.9906788,0.002279204,0.006454442,0.0001307141,0.0002353453,0.0001028162,0.00003239649,0.00004543228,0.00004085882],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01321483,"threshold_uncertainty_score":0.9999819,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2020402888048956,"score_gpt":0.4063018138214152,"score_spread":0.2042615250165197,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}